August 25, 2020

WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction

(WaveDyn™), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round. The round was led by new investor Tramway Venture Partners LP and included investments from a Phoenix Venture Partners LP affiliate and an additional angel investor. In connection with the financing, Waneta Tuttle of Tramway Venture Partners and Frank Levinson of Phoenix Venture Partners will join WaveDyn’s Board of Directors. The funds will support continued development of its ophthalmic measurement device with dynamic wavefront technology and subsequent clinical studies.

August 12, 2020

WaveFront Dynamics Names Jeff Kolberg as New Chief Commercial Officer

WaveFront Dynamics Inc an early stage ophthalmic medical device company, today announced that Jeff Kolberg has been appointed as the company’s Chief Commercial Officer (CCO). Mr. Kolberg joins the leadership team with extensive industry experience to lead WaveDyn’s corporate strategy and future commercialization of its products, including overseeing marketing, sales and service teams. The company is focusing efforts on its dynamic wavefront measurement device and advanced treatment solutions, which will help restore vision and quality of life for patients with highly aberrated eyes.

July 13, 2020

WaveFront Dynamics Announces Opening of New Corporate Headquarters in Albuquerque, NM

WaveFront Dynamics Inc., an early-stage ophthalmic medical device company, is expanding its operations with the opening of its new headquarters in Albuquerque, NM. The new facilities consisting of office, development labs, and manufacturing space will meet the needs of the company’s growth through its next stage of development and commercialization.

March 25th, 2020

BennuBio announces $5 Million in New Financing 

BennuBio Inc. a provider of advanced cell and particle instrumentation for the life science market. On March 25th, 2020 they announced it had closed on $5 million of a $7 million financing round. The series B financing was led by new investor Co-Win Ventures with additional investment by existing investors Tramway Venture Partners, Cottonwood Technology Fund, and Sun Mountain Capital. In connection with the financing, Xin Huang of Co-Win Ventures will join BennuBio’s Board of Directors.

April 30, 2019

Armonica Technologies to Present at the Upcoming 2019 EIPBN Conference

Armonica Technologies, Inc, an Albuquerque, NM-based company focused on developing a proprietary long-read DNA sequencing technology (the “Company”), announces that it will be presenting two papers at the upcoming 2019 Electron, Ion, and Photon Beam Technology and Nanofabrication International Conference (EIPBN). The EIPBN Conference is recognized as the foremost international meeting dedicated to lithographic science and technology and its application to micro and nanofabrication techniques. The conference brings together engineers and scientists from industries and universities all over the world to discuss recent progress and future trends

November 14, 2018

Armonica Technologies secures new patents advancing their long-read DNA successes

As it advances the stage of its technology, the Company is generating excitement within the scientific community. “I believe that Armonica has the potential to transform the genome sciences through ultra-high throughput DNA sequencing,” said Dr. Jeremy Edwards, Professor at the University of New Mexico Comprehensive Cancer Center and Scientific Advisor to the Company. “Previous nanopore technology has suffered from serious limitations, namely the ability to control the speed of DNA translocation through a nanopore. In recent years this problem has been partially mitigated using proteins positioned on the nanopore. Armonica has developed an optimal solution to this problem using innovative nanofabrication technology. I am very excited by the technology that Armonica is developing,”

September 4, 2018

UNM Tech spinoff attracts $1.5M investment

A new cell screening and analysis technology that accelerates tissue-processing rates by up to 100-fold is nearing market, boosted by a $1.5 million venture investment in local startup BennuBio. The company is commercializing a University of New Mexico breakthrough in flow-through cytometers, or cell meters, which are used to rapidly analyze millions, and often billions of cells for medical diagnostics and drug discovery. Today’s cytometers can process only about 10,000 cells per second because tissue samples are pushed through cytometers one at a time. In addition, when screening complex conglomerates of cells, the process slows down to 100 cells per second.

August 21, 2017

UNM Technology Accelerates Genomic Sequencing

Today, DNA sequencing is a tortuous process that often takes days and sometimes weeks to read a full human genome, but University of New Mexico researchers may have found a way to cut that down to minutes. Investors are now lining up behind UNM’s breakthrough, which they say could accelerate the healthcare industry’s use of “precision medicine” based on each individual’s unique DNA structure New Mexico-based Cottonwood Technology, Tramway Venture Partners and Sun Mountain Capital are jointly pumping an initial $1.5 million investment into Armonica Technologies Inc., a new startup that’s working to take UNM’s discovery to market.

May 23, 2017

New Venture Capital Fund Will Be Critical to Start-up Growth

New Mexico is still mired in muck from the recession, but better times may be coming for local entrepreneurs looking to start new businesses. About $40 million in new venture capital could soon be flowing into startups across the state now that the State Investment Council’s new Catalyst Fund has begun doling out money for local venture funds that want to pump up budding New Mexico companies. The Catalyst Fund, managed by Sun Mountain Capital in Santa Fe, approved the first $4.65 million in early May for three investment entities to back some of the wave of new businesses emerging from the state’s incubator and accelerator programs looking to take new products and services to market.

May 2, 2017

$40 Million Investment in New Mexico Startups

Today, Governor Susana Martinez announced $40 million worth of investments in New Mexico startups. A $20 million Catalyst Fund is being launched that will raise a matching $20 million in private equity for investments in local startups. The Catalyst Fund is expected to support more than 50 companies in New Mexico and will focus on aiding technology startups.

May 2, 2017

New state Catalyst Fund announces first awards

Many cash-strapped New Mexico start-ups may soon get a critical boost from a state-backed investment program that’s pumping an initial $4.65 million into three local venture funds. Gov. Susana Martinez announced Tuesday that the state’s new $20 million “Catalyst Fund” is making its first three commitments to investment funds managed by New Mexico State University, and by the Albuquerque-based firms Cottonwood Technology and Tramway Venture Partners. Those organizations will, in turn, match state money dollar-for-dollar, doubling the amount of new cash to become available for local startups seeking seed and early-stage capital.